[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351987-105":59,"doc-detail-351987-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","impact-of-cav13-l-type-calcium-channels-on-arrhythmogenesis-in-cancer","Impact of CaV1.3 L-Type Calcium Channels on Arrhythmogenesis in Cancer","","Cardiovascular disease and cancer remain the leading causes of death worldwide. Although cancer therapies improve survival, they also raise risks of cardiomyopathy, heart failure, and arrhythmias, restricting treatment options and harming long-term quality of life. CaV1.3, an L-type calcium channel encoded by CACNA1D, links cardiovascular disease and cancer by regulating calcium entry, pacemaking, conduction, and tumor proliferation, migration, and therapy resistance. Chemotherapy-driven oxidative stress, inflammation, hypoxia, and transcriptional changes modulate CaV1.3 expression and trafficking, destabilizing diastolic depolarization and promoting arrhythmias.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-cav13-l-type-calcium-channels-on-arrhythmogenesis-in-cancer/351987/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-cav13-l-type-calcium-channels-on-arrhythmogenesis-in-cancer/351987.png","ImageObject",300,407,{"name":92,"@type":93},"Anna Hans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CaV1.3 play in connecting cancer and cardiovascular complications?","Question",{"text":112,"@type":113},"CaV1.3 regulates calcium entry in cardiomyocytes and contributes to sinoatrial pacemaking and atrioventricular conduction. It also supports cancer progression by influencing proliferation, migration, and therapy resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can cancer therapies increase arrhythmia risk through CaV1.3?",{"text":117,"@type":113},"Chemotherapy-induced oxidative stress, inflammatory signaling, hypoxia, and transcriptional changes can modulate CaV1.3 expression, gating, splicing, and trafficking. These alterations destabilize diastolic depolarization and impair conduction, promoting arrhythmias.",{"name":119,"@type":110,"acceptedAnswer":120},"What models are proposed to study CaV1.3 dysregulation?",{"text":121,"@type":113},"The review highlights patient-specific induced pluripotent stem cell-derived cardiomyocytes as a platform to model CaV1.3 dysregulation and to support development of targeted therapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351987,1790322209,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review  \nImpact of CaV1.3 L-Type Calcium Channels on Arrhythmogenesis in Cancer  \nLianlen Joy Go Distor 1,2, Yvonne Sleiman 1, Jean-Baptiste Reisqs 1, Vamsi Krishna Murthy Ginjupalli 1, Michael Cupelli 1 and Mohamed Boutjdir 1,2,3, *  \nAcademic Editor: Ari-Pekka Koivisto  \nReceived: 8 May 2026  \nRevised: 18 June 2026  \nAccepted: 20 June 2026  \nPublished: 23 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Cardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY 11209, USA; [lianlenjoydistor@gmail.com](lianlenjoydistor@gmail.com) (L.J.G.D.); [yvonne_sleiman@hotmail.com](yvonne_sleiman@hotmail.com) (Y.S.); [jeanbaptiste.reisqs@gmail.com](jeanbaptiste.reisqs@gmail.com) (J.-B.R.); [vamsikrishna.ginjupalli@va.gov](vamsikrishna.ginjupalli@va.gov) (V.K.M.G.); [michael.cupelli@va.gov](michael.cupelli@va.gov) (M.C.)  \n2 Department of Medicine, Cell Biology and Pharmacology, State University of New York Downstate Health Sciences University, New York, NY 11203, USA  \n3 Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA  \n* [Correspondence: mohamed.boutjdir@va.gov](Correspondence: mohamed.boutjdir@va.gov)  \nAbstract  \nCardiovascular disease and cancer remain the leading causes of death worldwide. Although numerous cancer therapies have improved survival rates, they also increase the risk of cardiomyopathy, heart failure, and arrhythmias. These cardiovascular complications can limit treatment options and adversely affect the long-term quality of life of cancer survivors. CaV1.3, an L-type calcium channel encoded by CACNA1D, emerges as a central molecular mediator linking cardiovascular disease and cancer. It regulates calcium entry into cardiomyocytes and contributes to sinoatrial pacemaking and atrioventricular conduction. It also contributes to proliferation, migration, and therapy resistance in several cancers. Chemotherapy-induced oxidative stress, inflammatory signaling, hypoxia, and transcriptional changes can modulate the expression, gating, splicing, and trafficking of CaV1.3 channels. All these changes destabilize diastolic depolarization and impair conduction, thereby promoting arrhythmias in cancer patients. This review focuses on CaV1.3 biology in cardio-oncology, along with the mechanisms of chemotherapy-induced cardiotoxicity. It outlines the role of CaV1.3 as a key mediator linking cancer therapies to subsequent nodal dysfunction and increased arrhythmia susceptibility. It also expandson how patient-specific induced pluripotent stem cell-derived cardiomyocytes can model CaV1.3 dysregulation as well as support the development of targeted therapies. We propose that CaV1.3 represents a mechanistic bridge linking cancer therapy, calcium signaling, and cardiac electrophysiology, and that elucidating its pathophysiology may guide the design of targeted strategies in cardio-oncology.  \nKeywords: arrhythmia; cardio-oncology; cardiotoxicity; cardiovascular disease; CaV 1.3 L-type calcium channel  \n1. Introduction  \nCardiovascular disease (CVD) and cancer are the leading causes of death worldwide [1–4] . Early detection and improved therapies have increased survival rates for both diseases, but cardiac complications induced by cancer treatments are still a major concern [5,6] . Across oncology, patients receiving chemotherapy, targeted therapies, or immunotherapies exhibit higher rates of arrhythmias and heart failure compared with  \nboth pre-treatment cancer patients and the general population [7] . Atrial fibrillation (AF) is the most common rhythm disturbance among both cancer patients and cancer survivors, occurring in the presence or absence of cardiotoxic cancer therapies [8] . Additionally, cardiac dysfunction such as heart failure, cardiomyopathy, arrhythmias, and coronary artery disease","cbCaipDVIgBEqT1m","https://ap.wps.com/l/cbCaipDVIgBEqT1m","pdf",2389624,24,"English","# Abstract\n# Keywords\n# 1. Introduction\n# 2. CaV1.3 as a Key Player\n## 2.1. CaV1.3 in Physiological and Arrhythmogenic Cardiac Tissue","[{\"question\":\"What role does CaV1.3 play in connecting cancer and cardiovascular complications?\",\"answer\":\"CaV1.3 regulates calcium entry in cardiomyocytes and contributes to sinoatrial pacemaking and atrioventricular conduction. It also supports cancer progression by influencing proliferation, migration, and therapy resistance.\"},{\"question\":\"How can cancer therapies increase arrhythmia risk through CaV1.3?\",\"answer\":\"Chemotherapy-induced oxidative stress, inflammatory signaling, hypoxia, and transcriptional changes can modulate CaV1.3 expression, gating, splicing, and trafficking. These alterations destabilize diastolic depolarization and impair conduction, promoting arrhythmias.\"},{\"question\":\"What models are proposed to study CaV1.3 dysregulation?\",\"answer\":\"The review highlights patient-specific induced pluripotent stem cell-derived cardiomyocytes as a platform to model CaV1.3 dysregulation and to support development of targeted therapies.\"}]","Impact of CaV1.3 L-Type Calcium Channels on Arrhythmogenesis in Cancer | PDF",1790096682,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44d006da575dd3138962c9497d5da078.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8f65d0ea49343368b4722527cc9f3a1.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98f5283b860c18d73f06fc0fa62985d9.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f743b844aa95b082e611a5c1d98d39fa.webp",980,1385]